Dr. Thomas Dabrowski, MD

Dr. Dabrowski practices at Perlman Clinic in Chula Vista, California.

Dr. Dabrowski's NPI, 1295148658, was assigned on June 3, 2014. Dr. Dabrowski graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2007. Dr. Dabrowski's California license number on file is A130486.

Dr. Dabrowski's primary practice is Perlman Clinic, at 299 J St, Chula Vista, CA 91910-5831. The practice phone is (858) 799-2366.

Dr. Dabrowski's primary practice is Perlman Clinic in Chula Vista, California. The medical group on file is Perlman Clinic. Dmand AI also links Dr. Dabrowski to 3 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dabrowski practices, 3 sites in all. Vendor and product names are available with a free account.

General practice is Dr. Dabrowski's primary specialty in the NPI Registry, under taxonomy code 208D00000X. Dr. Dabrowski has a license on file in California.

Dmand AI lists acid reflux, acute sinusitis, acute skin infection, ankle or foot injury, chronic diabetes, conjunctivitis, ear eustachian tube disorders and ear infection among the conditions Dr. Dabrowski treats.

CMS data shows 82 Medicare services from Dr. Dabrowski across 3 procedure codes in 2024, all of them office visits, for 68 Medicare patients. Medicare paid $7,883 for them. Every service was in an office.

CMS counts 68 Medicare patients who saw Dr. Dabrowski in 2026. The largest group is 65 to 74, with 27 patients. 63% of them have high cholesterol, and 56% have high blood pressure. 24% are also on Medicaid. Their average risk score is 0.90, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dabrowski's median patient age at 60, with 37% women.

In 2026, Dr. Dabrowski wrote 1,044 Medicare Part D claims for 200 patients. 86% of them were for generic drugs. CMS names the drug for 616 of them, across 20 drugs with 11 or more claims each, at $24,677 in total drug cost. In 2023, CMS named 106 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Dabrowski for performance year 2026, reported as part of a group. Dr. Dabrowski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dabrowski as offering telehealth.

CMS Open Payments shows 36 general payments to Dr. Dabrowski from 15 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. ViiV Healthcare Company paid the most, $285.

Dr. Dabrowski graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2007.

Dr. Dabrowski is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.